RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval
June 01, 2023 at 11:46 AM EDT
Global market for RSV vaccine could reach $17 billion by 2033, analysts say.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
